Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004185. doi: 10.1002/14651858.CD004185.pub2
Methods Eight-week double-blind, randomised study.
Participants Outpatients with a diagnosis of depressive episode less than 2 months duration, according to DSM-III criteria, with a minimum score of 25 on the MADRS. Age range: 18-65 yeras old.
Exclusion criteria: absence of resistance to mianserin or fluoxetine, absence of associated psychotropic treatment, with the exception of prazepam (40 mg/day)
Interventions Fluoxetine: 33 participants.
Mianserin: 32 participants.
Fluoxetine dose range: 20-40 mg/day.
Mianserin dose range: 60-90 mg/day.
Outcomes Hamilton Rating Scale for Depression, Hamilton Rating Scale for Anxiety, Montgomery and Asberg Scale for Depression (MADRS)
Notes Funding: by industry
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear